TEMIS Selected to Provide Semantic Indexing and Content Enrichment Solution for Gannett
News Apr 05, 2012
TEMIS has announced that it has signed a license and services agreement for its flagship software solution, Luxid®, with Gannett Co., Inc., an international media and marketing solutions company.
Gannett has chosen to deploy TEMIS' Luxid® semantic tagging and linking software as a tagging engine that assists in the categorization of news articles and consistent indexing of content against a common taxonomy.
“Gannett is further strengthening its enterprise-wide content management expertise and the efficiency of its digital and mobile products and services with the selection of TEMIS,” said Jack Williams, President of Gannett Digital Ventures.
“We are honored that our flagship Luxid® for Content Enrichment Platform has been selected by an industry leader with the strength, ambition and vision of Gannett," said Guillaume Mazieres, EVP North American Operations of TEMIS.
Mazieres continued, "Luxid® has shown it is the most capable content enrichment solution serving the publishing industry today. Luxid® will help Gannett deliver high-quality, easily findable, targeted content within an unparalleled digital experience.”
Gannett will first deploy Luxid® within its internal editorial workflow and content management processes.
The company will later enhance online and mobile readers’ navigation and content discovery experience across the company’s full suite of digital products.
A new platform ensures that web services adhere to users’ preferences on how their data are stored and shared in the cloud. In a paper being presented at this week’s USENIX Networked Systems Design and Implementation conference, the researchers behind the platform, called Riverbed, show how it forces data center servers to only use data in ways that users explicitly approve.READ MORE
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.READ MORE